From: Ranking metrics in gene set enrichment analysis: do they matter?
GEO | Target KEGG ID | Disease/KEGG pathway name | Tissue | Sample Size (Control+Case) |
---|---|---|---|---|
GSE1145 | hsa:05414 | Dilated cardiomyopathy | Left Ventricle | 26 (11+15) |
GSE14924_CD4 | hsa:05221 | Acute myeloid leukemia | CD4 T cells | 20 (10+10) |
GSE14924_CD8 | hsa:05221 | Acute myeloid leukemia | CD8 T cells | 21 (11+10) |
GSE16759 | hsa:05010 | Alzheimer’s disease | Parietal lobe | 8 (4+4) |
GSE24739_G0 | hsa:05220 | Chronic myeloid leukemia | Peripheral blood | 12 (4+8) |
GSE24739_G1 | hsa:05220 | Chronic myeloid leukemia | Peripheral blood | 12 (4+8) |
GSE32676 | hsa:05212 | Pancreatic cancer | Pancreas | 32 (7+25) |
GSE4183 | hsa:05210 | Colorectal cancer | Colon | 23 (8+15) |
GSE1297 | hsa:05010 | Alzheimer’s disease | Hipopocampal CA1 | 16 (9+7) |
GSE14762 | hsa:05211 | Renal Cancer | Kidney | 21 (12+9) |
GSE19188 | hsa:05223 | Non-small cell lung cancer | Lung | 153 (62+91) |
GSE19728 | hsa:05214 | Glioma | Brain | 21 (4+17) |
GSE20153 | hsa:05012 | Parkinson’s disease | Lymphoblasts | 16 (8+8) |
GSE20291 | hsa:05012 | Parkinson’s disease | Ppstmortem brain putmen | 33 (19+14) |
GSE21354 | hsa:05214 | Glioma | Brain, Spine | 17 (4+13) |
GSE3585 | hsa:05414 | Dilated cardiomyopathy | Subendocardial left ventricle | 12 (5+7) |
GSE4107 | hsa:05210 | Colorectal cancer | Mucosa | 22 (10+12) |
GSE5281_EC | hsa:05010 | Alzheimer’s disease | Entorhinal cortex | 21 (12+9) |
GSE5281_HIP | hsa:05010 | Alzheimer’s disease | Hippocampus | 23 (13+10) |
GSE5281_VCX | hsa:05010 | Alzheimer’s disease | Primary visual cortex | 31 (12+19) |
GSE781 | hsa:05211 | Renal Cancer | Kidney | 17 (5+12) |
GSE8762 | hsa:05016 | Huntington’s disease | Lymphocytes | 22 (10+12) |
GSE9348 | hsa:05210 | Colorectal cancer | Colon | 82 (12+70) |
GSE9476 | hsa:05221 | Acute myeloid leukemia | Peripheral Blood | 63 (37+26) |
GSE6344 | hsa:05211 | Renal Cancer | Kidney | 20 (9+11) |
GSE15641 | hsa:05211 | Renal Cancer | Kidney | 55 (23+32) |
GSE14994 | hsa:05211 | Renal Cancer | Kidney | 30 (8+22) |
GSE11024 | hsa:05211 | Renal Cancer | Kidney | 22 (12+10) |